Leica Biosystems announced August 11, 2026 it won FDA clearance for what it calls the first standalone AI-assisted quality control tool for digital pathology slide scanning, aimed at catching scanning defects before they corrupt downstream AI diagnostics.
A WHO Europe forum on September 1, 2026 argued that health AI progress should be judged by the strength of governance frameworks rather than deployment speed, building on a 2025 dialogue that surveyed experts from 105 countries.
Samsung Research disclosed two new on-device AI foundation models, xMAE and HiMAE, that analyze wearable heart, sleep and activity biosignals locally on a smartwatch without cloud processing, though both remain research projects without a release date.
Johns Hopkins researchers reported July 31, 2026 that their AI-powered DELFI liquid biopsy blood test detected liver cancer consistently across 377 patients from Guatemala and Romania, two populations with very different disease pathways.
A whistleblower lawsuit filed July 6, 2026 alleges Mayo Clinic staff concealed a 67% error rate in its internally built AI assistant MAYA and retaliated against the former research operations director who raised the concern.
Cooper University Health Care has adopted hellocare.ai's computer-vision platform to power AI-assisted hospital rooms, joining WVU Medicine and MultiCare in a growing trend of using virtual nursing and automated fall detection to stretch scarce nursing staff.
Advocate Health is deploying AI startup Lind's platform to automatically screen cancer patients for clinical trial eligibility, aiming to fix a system in which only about 5% of eligible patients nationally ever enroll in a trial.
A randomized trial of an AI tool co-developed by Mayo Clinic and Bayesian Health found earlier palliative care referrals cut 90-day hospital readmissions by 28%, offering rare outcome-level proof for a predictive hospital AI system.
Deep Origin said in August 2026 that its hybrid physics-and-AI drug discovery platform achieved a 31% hit rate against a cancer immunotherapy enzyme, nearly 100 times higher than typical machine-learning-only screening approaches.
MMRO announced September 4, 2026 that it earned URAC's Artificial Intelligence in Health Care Accreditation, becoming one of the first independent medical review organizations certified under the year-old voluntary AI governance program.